img

Global Angina Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Angina Market Research Report 2024

Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
According to MRAResearch’s new survey, global Angina market is projected to reach US$ 14180 million in 2033, increasing from US$ 10400 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Angina market research.
Key companies engaged in the Angina industry include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, Milestone Pharmaceuticals, Juventas Therapeutics, ViroMed and Kuhnil Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Angina were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Angina market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Angina market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Segment by Type
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine

Segment by Application


Clinics
Hospitals
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Angina report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angina Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Beta Blockers
1.2.3 Calcium Antagonists
1.2.4 Anticoagulants
1.2.5 Antiplatelet
1.2.6 Nitrates
1.2.7 ACE Inhibitors
1.2.8 Ranolazine
1.3 Market by Application
1.3.1 Global Angina Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angina Market Perspective (2018-2033)
2.2 Angina Growth Trends by Region
2.2.1 Global Angina Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Angina Historic Market Size by Region (2018-2023)
2.2.3 Angina Forecasted Market Size by Region (2024-2033)
2.3 Angina Market Dynamics
2.3.1 Angina Industry Trends
2.3.2 Angina Market Drivers
2.3.3 Angina Market Challenges
2.3.4 Angina Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angina Players by Revenue
3.1.1 Global Top Angina Players by Revenue (2018-2023)
3.1.2 Global Angina Revenue Market Share by Players (2018-2023)
3.2 Global Angina Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Angina Revenue
3.4 Global Angina Market Concentration Ratio
3.4.1 Global Angina Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angina Revenue in 2022
3.5 Angina Key Players Head office and Area Served
3.6 Key Players Angina Product Solution and Service
3.7 Date of Enter into Angina Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Angina Breakdown Data by Type
4.1 Global Angina Historic Market Size by Type (2018-2023)
4.2 Global Angina Forecasted Market Size by Type (2024-2033)
5 Angina Breakdown Data by Application
5.1 Global Angina Historic Market Size by Application (2018-2023)
5.2 Global Angina Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Angina Market Size (2018-2033)
6.2 North America Angina Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Angina Market Size by Country (2018-2023)
6.4 North America Angina Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angina Market Size (2018-2033)
7.2 Europe Angina Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Angina Market Size by Country (2018-2023)
7.4 Europe Angina Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angina Market Size (2018-2033)
8.2 Asia-Pacific Angina Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Angina Market Size by Region (2018-2023)
8.4 Asia-Pacific Angina Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angina Market Size (2018-2033)
9.2 Latin America Angina Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Angina Market Size by Country (2018-2023)
9.4 Latin America Angina Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angina Market Size (2018-2033)
10.2 Middle East & Africa Angina Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Angina Market Size by Country (2018-2023)
10.4 Middle East & Africa Angina Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Angina Introduction
11.1.4 Amgen Revenue in Angina Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Taxus Cardium Pharmaceuticals
11.2.1 Taxus Cardium Pharmaceuticals Company Detail
11.2.2 Taxus Cardium Pharmaceuticals Business Overview
11.2.3 Taxus Cardium Pharmaceuticals Angina Introduction
11.2.4 Taxus Cardium Pharmaceuticals Revenue in Angina Business (2018-2023)
11.2.5 Taxus Cardium Pharmaceuticals Recent Development
11.3 LegoChem Biosciences
11.3.1 LegoChem Biosciences Company Detail
11.3.2 LegoChem Biosciences Business Overview
11.3.3 LegoChem Biosciences Angina Introduction
11.3.4 LegoChem Biosciences Revenue in Angina Business (2018-2023)
11.3.5 LegoChem Biosciences Recent Development
11.4 Lee’s Pharmaceutical
11.4.1 Lee’s Pharmaceutical Company Detail
11.4.2 Lee’s Pharmaceutical Business Overview
11.4.3 Lee’s Pharmaceutical Angina Introduction
11.4.4 Lee’s Pharmaceutical Revenue in Angina Business (2018-2023)
11.4.5 Lee’s Pharmaceutical Recent Development
11.5 Milestone Pharmaceuticals
11.5.1 Milestone Pharmaceuticals Company Detail
11.5.2 Milestone Pharmaceuticals Business Overview
11.5.3 Milestone Pharmaceuticals Angina Introduction
11.5.4 Milestone Pharmaceuticals Revenue in Angina Business (2018-2023)
11.5.5 Milestone Pharmaceuticals Recent Development
11.6 Juventas Therapeutics
11.6.1 Juventas Therapeutics Company Detail
11.6.2 Juventas Therapeutics Business Overview
11.6.3 Juventas Therapeutics Angina Introduction
11.6.4 Juventas Therapeutics Revenue in Angina Business (2018-2023)
11.6.5 Juventas Therapeutics Recent Development
11.7 ViroMed
11.7.1 ViroMed Company Detail
11.7.2 ViroMed Business Overview
11.7.3 ViroMed Angina Introduction
11.7.4 ViroMed Revenue in Angina Business (2018-2023)
11.7.5 ViroMed Recent Development
11.8 Kuhnil Pharmaceutical
11.8.1 Kuhnil Pharmaceutical Company Detail
11.8.2 Kuhnil Pharmaceutical Business Overview
11.8.3 Kuhnil Pharmaceutical Angina Introduction
11.8.4 Kuhnil Pharmaceutical Revenue in Angina Business (2018-2023)
11.8.5 Kuhnil Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Angina Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Beta Blockers
Table 3. Key Players of Calcium Antagonists
Table 4. Key Players of Anticoagulants
Table 5. Key Players of Antiplatelet
Table 6. Key Players of Nitrates
Table 7. Key Players of ACE Inhibitors
Table 8. Key Players of Ranolazine
Table 9. Global Angina Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Angina Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Angina Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Angina Market Share by Region (2018-2023)
Table 13. Global Angina Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Angina Market Share by Region (2024-2033)
Table 15. Angina Market Trends
Table 16. Angina Market Drivers
Table 17. Angina Market Challenges
Table 18. Angina Market Restraints
Table 19. Global Angina Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Angina Market Share by Players (2018-2023)
Table 21. Global Top Angina Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina as of 2022)
Table 22. Ranking of Global Top Angina Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Angina Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Angina Product Solution and Service
Table 26. Date of Enter into Angina Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Angina Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Angina Revenue Market Share by Type (2018-2023)
Table 30. Global Angina Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Angina Revenue Market Share by Type (2024-2033)
Table 32. Global Angina Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Angina Revenue Market Share by Application (2018-2023)
Table 34. Global Angina Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Angina Revenue Market Share by Application (2024-2033)
Table 36. North America Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Angina Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Angina Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Angina Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Angina Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Angina Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Angina Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Angina Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Angina Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Angina Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Angina Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Angina Market Size by Country (2024-2033) & (US$ Million)
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Angina Product
Table 54. Amgen Revenue in Angina Business (2018-2023) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Taxus Cardium Pharmaceuticals Company Detail
Table 57. Taxus Cardium Pharmaceuticals Business Overview
Table 58. Taxus Cardium Pharmaceuticals Angina Product
Table 59. Taxus Cardium Pharmaceuticals Revenue in Angina Business (2018-2023) & (US$ Million)
Table 60. Taxus Cardium Pharmaceuticals Recent Development
Table 61. LegoChem Biosciences Company Detail
Table 62. LegoChem Biosciences Business Overview
Table 63. LegoChem Biosciences Angina Product
Table 64. LegoChem Biosciences Revenue in Angina Business (2018-2023) & (US$ Million)
Table 65. LegoChem Biosciences Recent Development
Table 66. Lee’s Pharmaceutical Company Detail
Table 67. Lee’s Pharmaceutical Business Overview
Table 68. Lee’s Pharmaceutical Angina Product
Table 69. Lee’s Pharmaceutical Revenue in Angina Business (2018-2023) & (US$ Million)
Table 70. Lee’s Pharmaceutical Recent Development
Table 71. Milestone Pharmaceuticals Company Detail
Table 72. Milestone Pharmaceuticals Business Overview
Table 73. Milestone Pharmaceuticals Angina Product
Table 74. Milestone Pharmaceuticals Revenue in Angina Business (2018-2023) & (US$ Million)
Table 75. Milestone Pharmaceuticals Recent Development
Table 76. Juventas Therapeutics Company Detail
Table 77. Juventas Therapeutics Business Overview
Table 78. Juventas Therapeutics Angina Product
Table 79. Juventas Therapeutics Revenue in Angina Business (2018-2023) & (US$ Million)
Table 80. Juventas Therapeutics Recent Development
Table 81. ViroMed Company Detail
Table 82. ViroMed Business Overview
Table 83. ViroMed Angina Product
Table 84. ViroMed Revenue in Angina Business (2018-2023) & (US$ Million)
Table 85. ViroMed Recent Development
Table 86. Kuhnil Pharmaceutical Company Detail
Table 87. Kuhnil Pharmaceutical Business Overview
Table 88. Kuhnil Pharmaceutical Angina Product
Table 89. Kuhnil Pharmaceutical Revenue in Angina Business (2018-2023) & (US$ Million)
Table 90. Kuhnil Pharmaceutical Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Angina Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Angina Market Share by Type: 2022 VS 2033
Figure 3. Beta Blockers Features
Figure 4. Calcium Antagonists Features
Figure 5. Anticoagulants Features
Figure 6. Antiplatelet Features
Figure 7. Nitrates Features
Figure 8. ACE Inhibitors Features
Figure 9. Ranolazine Features
Figure 10. Global Angina Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Angina Market Share by Application: 2022 VS 2033
Figure 12. Clinics Case Studies
Figure 13. Hospitals Case Studies
Figure 14. Other Case Studies
Figure 15. Angina Report Years Considered
Figure 16. Global Angina Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Angina Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Angina Market Share by Region: 2022 VS 2033
Figure 19. Global Angina Market Share by Players in 2022
Figure 20. Global Top Angina Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Angina Revenue in 2022
Figure 22. North America Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Angina Market Share by Country (2018-2033)
Figure 24. United States Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Angina Market Share by Country (2018-2033)
Figure 28. Germany Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Angina Market Share by Region (2018-2033)
Figure 36. China Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Angina Market Share by Country (2018-2033)
Figure 44. Mexico Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Angina Market Share by Country (2018-2033)
Figure 48. Turkey Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Angina Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Angina Business (2018-2023)
Figure 51. Taxus Cardium Pharmaceuticals Revenue Growth Rate in Angina Business (2018-2023)
Figure 52. LegoChem Biosciences Revenue Growth Rate in Angina Business (2018-2023)
Figure 53. Lee’s Pharmaceutical Revenue Growth Rate in Angina Business (2018-2023)
Figure 54. Milestone Pharmaceuticals Revenue Growth Rate in Angina Business (2018-2023)
Figure 55. Juventas Therapeutics Revenue Growth Rate in Angina Business (2018-2023)
Figure 56. ViroMed Revenue Growth Rate in Angina Business (2018-2023)
Figure 57. Kuhnil Pharmaceutical Revenue Growth Rate in Angina Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed